KRAS and colorectal carcinoma: (2015) also found that in most CRC, the majority of neoplastic cells carry mutant KRAS or NRAS, while in BRAF‐ and PIK3CA‐mutant cases, only a fraction of neoplastic cells harbor the mutant allele.